Association of dopamine D1 receptor gene polymorphism with schizophrenia: A meta-analysis

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 1133-1139

  Pan, Yu Qing ^a   Yao, Jun ^a   Wang, Bao Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Genetics; Psychiatry; SNP; Susceptibility

Indexed keywords

DOPAMINE 1 RECEPTOR;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; DRD1 GENE; ETHNICITY; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; PATHOGENESIS; RISK FACTOR; SCHIZOPHRENIA;

EID: 84903214433     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S63776     Document Type: Article

References (44)

1. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30: 67-76.
2. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60(12):1187-1192.
3. Schierding W, Cutfield WS, O'Sullivan JM. The missing story behind Genome Wide Association Studies: single nucleotide polymorphisms in gene deserts have a story to tell. Front Genet. 2014;5:39.
4. Rees E, Walters JT, Georgieva L, et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry. 2014;204(2): 108-114.
5. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull. 2009;35(3): 549-562.
6. Abi-Dargham A, Meyer JM. Schizophrenia: the role of dopamine and glutamate. J Clin Psychiatry. 2014;75(3):274-275.
7. Rybakowski JK, Borkowska A, Czerski PM, Kapelski P, Dmitrzak-Weglarz M, Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J Neural Transm. 2005;112(11):1575-1582.
8. Zheng Y, Wang X, Gu N, et al. A two-stage linkage analysis of Chinese schizophrenia pedigrees in 10 target chromosomes. Biochem Biophys Res Commun. 2006;342(4):1049-1057.
9. Escamilla MA, Ontiveros A, Nicolini H, et al. A genome-wide scan for schizophrenia and psychosis susceptibility loci in families of Mexican and Central American ancestry. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(2):193-199.
10. Sklar P, Pato MT, Kirby A, et al. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry. 2004;9(2):213-218.
11. Hwang R, Shinkai T, De Luca V, et al. Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response. J Psychopharmacol. 2007;21(7):718-727.
12. Okubo Y, Suhara T, Suzuki K, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 1997; 385(6617):634-636.
13. Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry. 2002;159(5):761-767.
14. Abi-Dargham A, Mawlawi O, Lombardo I, et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci. 2002; 22(9):3708-3719.
15. Sedvall G, Pauli S, Karlsson P, et al. PET imaging of neuroreceptors in schizophrenia. Eur Neuropsychopharmacol. 1995;5 Suppl:S25-S30.
16. Dollfus S, Campion D, Vasse T, et al. Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems. Biol Psychiatry. 1996;40(5):419-421.
17. Zhang C, Xie B, Du YS, et al. [Gene-gene interaction between DNMT3B and DRD1 in schizophrenia]. Zhonghua Yi Xue Za Zhi. 2010;90(43): 3059-3062. Chinese.
18. Howe AS, Leung T, Bani-Fatemi A, et al. Lack of association between dopamine-β hydroxylase gene and a history of suicide attempt in schizophrenia: comparison of molecular and statistical haplotype analyses. Psychiatr Genet. 2014;24(3):110-115.
19. Potkin SG, Basile VS, Jin Y, et al. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol Psychiatry. 2003;8(1):109-113.
20. Williams GV, Castner SA. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience. 2006; 139(1):263-276.
21. Fung MM, Rana BK, Tang CM, et al. Dopamine D1 receptor (DRD1) genetic polymorphism: pleiotropic effects on heritable renal traits. Kidney Int. 2009;76(10):1070-1080.
22. Munafò MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20(9):439-444.
23. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28(2):123-137.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
26. Egger M. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
27. Cichon S, Nöthen MM, Rietschel M, Körner J, Propping P. Single-strand conformation analysis (SSCA) of the dopamine D1 receptor gene (DRD1) reveals no significant mutation in patients with schizophrenia and manic depression. Biol Psychiatry. 1994;36(12):850-853.
28. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, et al. Dopamine receptor D1 gene-48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology. 2006;53(1):46-50.
29. Hu Y, Wang G, Wang H, Liu Z, Tang J. Distribution of dopamine D1 receptor-48A/G gene polymorphism of healthy Han population in China. Chinese Journal Of Clinical Rehabilitation. 2005;9(20):152-153.
30. Iwata Y, Matsumoto H, Minabe Y, et al. Early-onset schizophrenia and dopamine-related gene polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2003;116B(1):23-26.
31. Kojima H, Ohmori O, Shinkai T, Terao T, Suzuki, Abe K. Dopamine D1 receptor gene polymorphism and schizophrenia in Japan. Am J Med Genet. 1999;88(2):116-119.
32. Zhang C, Fang Y, Xie B, et al. No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia. Psychiatry Res. 2010;177(3):350-353.
33. Zhu F, Yan CX, Wang Q, et al. An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia. Brain Res. 2011;1420:106-113.
34. Du Z, Zhang Y, Cheng Y, Zhu C.-94 G/A polymorphism in the dopamine D1 receptor gene is associated with schizophrenia in a Chinese Han population from Shandong province. Neural Regen Res. 2011; 06(19):1484-1487.
35. Narayanan NS, Land BB, Solder JE, Deisseroth K, DiLeone RJ. Prefrontal D1 dopamine signaling is required for temporal control. Proc Natl Acad Sci U S A. 2012;109(50):20726-20731.
36. Girault JA, Greengard. The neurobiology of dopamine signaling. Arch Neurol. 2004;61(5):641-644.
37. Ni X, Trakalo JM, Mundo E, et al. Linkage disequilibrium between dopamine D1 receptor gene (DRD1) and bipolar disorder. Biol Psychiatry. 2002;52(12):1144-1150.
38. Hoenicka J, Garrido E, Ponce G, et al. Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(4):948-954.
39. Batel P, Houchi H, Daoust M, Ramoz N, Naassila M, Gorwood. A haplotype of the DRD1 gene is associated with alcohol dependence. Alcohol Clin Exp Res. 2008;32(4):567-572.
40. Bobb AJ, Addington AM, Sidransky E, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet. 2005;134B(1):67-72.
41. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD. Significant association of DRD1 with nicotine dependence. Hum Genet. 2008; 123(2):133-140.
42. Novak G, LeBlanc M, Zai C, et al. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet. 2010;74(4):291-298.
43. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40(7):827-834.
44. Schmitt A, Malchow B, Hasan A, Falkai P. The impact of environmental factors in severe psychiatric disorders. Front Neurosci. 2014;8:19.